Skip to main content
Fig. 2 | BMC Musculoskeletal Disorders

Fig. 2

From: Osteoclasts secrete leukemia inhibitory factor to promote abnormal bone remodeling of subchondral bone in osteoarthritis

Fig. 2

(A, B) Inhibition of osteoclasts can reduce the ratio of matrix metalloproteinase-13 (MMP-13) positive cells in articular cartilage at 4 weeks after ACLT surgery. Immunostaining and quantitative analysis for MMP-13. (C, D) Immunofluorescence staining and quantitative analysis for collagen X. Scale bar, 50 μm. Means ± SD; **p < 0.01 compared to the the sham group, ##p < 0.01 compared to the the vehicle group

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us